Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study
Objective. Inborn errors of metabolism (IEM) are genetic conditions that are sometimes associated with intellectual developmental disorders (IDD). The aim of this study is to contribute to the metabolic characterization of IDD of unknown etiology in Mexico. Materials and methods. Metabolic screenin...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Nacional de Salud Pública
2017-07-01
|
Series: | Salud Pública de México |
Subjects: | |
Online Access: | http://www.saludpublica.mx/index.php/spm/article/view/8668 |
id |
doaj-77656ec2a3a74419b711d65277c19ff7 |
---|---|
record_format |
Article |
spelling |
doaj-77656ec2a3a74419b711d65277c19ff72020-11-24T22:37:40ZengInstituto Nacional de Salud PúblicaSalud Pública de México0036-36341606-79162017-07-01594, jul-ago42342810.21149/866816388Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico StudyIsabel Ibarra-González0Rocío Rodríguez-Valentín1Eduardo Lazcano-Ponce2Marcela Vela-Amieva3Unidad de Génetica de la Nutrición. Instituto de Investigaciones Biomédicas, UNAM-Instituto Nacional de PediatríaCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MéxicoCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MéxicoLaboratorio de Errores Innatos del Metabolismo y Tamiz, Instituto Nacional de Pediatría, México.Objective. Inborn errors of metabolism (IEM) are genetic conditions that are sometimes associated with intellectual developmental disorders (IDD). The aim of this study is to contribute to the metabolic characterization of IDD of unknown etiology in Mexico. Materials and methods. Metabolic screening using tandem mass spectrometry and fluorometry will be performed to rule out IEM. In addition,target metabolomic analysis will be done to characterize the metabolomic profile of patients with IDD. Conclusion. Identification of new metabolomic profiles associated withIDD of unknown etiology and comorbidities will contribute to the development of novel diagnostic and therapeutic schemes for the prevention and treatment of IDD in Mexico.http://www.saludpublica.mx/index.php/spm/article/view/8668Intellectual development disordersscreeninginborn errors metabolismmetabolomics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Isabel Ibarra-González Rocío Rodríguez-Valentín Eduardo Lazcano-Ponce Marcela Vela-Amieva |
spellingShingle |
Isabel Ibarra-González Rocío Rodríguez-Valentín Eduardo Lazcano-Ponce Marcela Vela-Amieva Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study Salud Pública de México Intellectual development disorders screening inborn errors metabolism metabolomics |
author_facet |
Isabel Ibarra-González Rocío Rodríguez-Valentín Eduardo Lazcano-Ponce Marcela Vela-Amieva |
author_sort |
Isabel Ibarra-González |
title |
Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study |
title_short |
Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study |
title_full |
Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study |
title_fullStr |
Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study |
title_full_unstemmed |
Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study |
title_sort |
metabolic screening and metabolomics analysis in the intellectual developmental disorders mexico study |
publisher |
Instituto Nacional de Salud Pública |
series |
Salud Pública de México |
issn |
0036-3634 1606-7916 |
publishDate |
2017-07-01 |
description |
Objective. Inborn errors of metabolism (IEM) are genetic conditions that are sometimes associated with intellectual developmental disorders (IDD). The aim of this study is to contribute to the metabolic characterization of IDD of unknown etiology in Mexico. Materials and methods. Metabolic screening using tandem mass spectrometry and fluorometry will be performed to rule out IEM. In addition,target metabolomic analysis will be done to characterize the metabolomic profile of patients with IDD. Conclusion. Identification of new metabolomic profiles associated withIDD of unknown etiology and comorbidities will contribute to the development of novel diagnostic and therapeutic schemes for the prevention and treatment of IDD in Mexico. |
topic |
Intellectual development disorders screening inborn errors metabolism metabolomics |
url |
http://www.saludpublica.mx/index.php/spm/article/view/8668 |
work_keys_str_mv |
AT isabelibarragonzalez metabolicscreeningandmetabolomicsanalysisintheintellectualdevelopmentaldisordersmexicostudy AT rociorodriguezvalentin metabolicscreeningandmetabolomicsanalysisintheintellectualdevelopmentaldisordersmexicostudy AT eduardolazcanoponce metabolicscreeningandmetabolomicsanalysisintheintellectualdevelopmentaldisordersmexicostudy AT marcelavelaamieva metabolicscreeningandmetabolomicsanalysisintheintellectualdevelopmentaldisordersmexicostudy |
_version_ |
1725716159399985152 |